Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The dose-rate effect in human tumour cells.

G G Steel1, J M Deacon, G M Duchesne

  • 1Radiotherapy Research Unit, Institute of Cancer Research, Sutton, Surrey, U.K.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|August 1, 1987
PubMed
Summary

Low dose-rate radiation therapy effectively distinguishes between human tumor cell lines with different radiosensitivities. This finding suggests that some tumors may benefit from hyperfractionation or low dose-rate irradiation, while others may not.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Appendix 9: Testicular seminoma and non-seminoma: eUpdate published online 29 June 2017 (www.esmo.org/Guidelines/Genitourinary-Cancers).

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers).

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Area of Science:

  • Radiation Oncology
  • Cellular Radiobiology

Background:

  • Understanding tumor cell radiation response is crucial for optimizing cancer therapy.
  • Dose rate significantly influences radiation effectiveness, impacting cell survival and repair.

Purpose of the Study:

  • To investigate the radiation response of human tumor cell lines across a range of low dose rates.
  • To compare the efficacy of low dose-rate versus high dose-rate irradiation in discriminating radiosensitivity.
  • To analyze cellular recovery mechanisms using split-dose experiments.

Main Methods:

  • Irradiation of 12 human tumor cell lines at dose rates from 1.6 to 150 cGy/min.
  • Mathematical modeling (LPL and Incomplete Repair models) to analyze dose-rate effects.
  • Split-dose experiments on 17 human tumor cell lines to assess recovery kinetics.

Related Experiment Videos

Main Results:

  • Low dose-rate irradiation showed significant sparing effects, varying widely among cell lines.
  • Low dose-rate irradiation better discriminated between cell lines of differing radiosensitivity compared to high dose rate.
  • Split-dose recovery half-times were generally longer than those from dose-rate effect analysis, suggesting a two-component recovery process.

Conclusions:

  • Cellular repair capacity and lesion repairability are key factors in low dose-rate radiation response.
  • Low dose-rate sparing is a more reliable measure of cellular recovery than split-dose recovery.
  • Clinical strategies like hyperfractionation or low dose-rate irradiation should be tailored to specific tumor types based on their radiation response characteristics.